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Introduction: Whilst the relationship between lipids and cardiovascular mortality has been well studied
and appears to be controversial, very little has been explored in the context of rural-to-urban migration
in low-resource settings.
Objective: Determine the proﬁle and related factors for HDL-c patterns (isolated and non-isolated low
HDL-c) in three population-based groups according to their migration status, and determine the effect of
HDL-c patterns on the rates of cardiovascular outcomes (i.e. non-fatal stroke and non-fatal myocardial
infarction) and mortality.
Methods: Cross-sectional and 5-year longitudinal data from the PERUMIGRANT study, designed to assess
the effect of migration on cardiovascular risk proﬁles and mortality in Peru. Two different analyses were
performed: ﬁrst, we estimated prevalence and associated factors with isolated and non-isolated low
HDL-c at baseline. Second, using longitudinal information, relative risk ratios (RRR) of composite out-
comes of mortality, non-fatal stroke and non-fatal myocardial infarction were calculated according to
HDL-c levels at baseline.
Results: Data from 988 participants, rural (n ¼ 201), rural-to-urban migrants (n ¼ 589), and urban
(n ¼ 199) groups, was analysed. Low HDL-c was present in 56.5% (95%CI: 53.4%e59.6%) without differ-
ences by study groups. Isolated low HDL-c was found in 36.5% (95%CI: 33.5e39.5%), with differences
between study groups. In multivariable analysis, urban group (vs. rural), female gender, overweight and
obesity were independently associated with isolated low HDL-c. Only female gender, overweight and
obesity were associated with non-isolated low HDL-c. Longitudinal analyses showed that non-isolated
low HDL-c increased the risk of negative cardiovascular outcomes (RRR ¼ 3.46; 95%CI: 1.23e9.74).
Conclusions: Isolated low HDL-c was the most common dyslipidaemia in the study population and was
more frequent in rural subjects. Non-isolated low HDL-c increased three-to fourfold the 5-year risk of
cardiovascular outcomes.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
Cardiovascular disease-related deaths disproportionally affectellence in Chronic Diseases,
97, Miraﬂores, Lima, Peru.
da).
r Ireland Ltd. This is an open acceslow- and middle-income countries [1], and adverse lipid proﬁles
have been linked to these events [2]. High-density lipoprotein
cholesterol (HDL-c) is a signiﬁcant predictor of major cardiovas-
cular events, even after adjustment by other risk factors including
baseline low-density lipoprotein cholesterol (LDL-c) level [3]. The
role of HDL-c as a major contributor of myocardial infarction has
been challenged [4] and current evidence supports a relationships article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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HDL-c cholesterol with coronary heart disease [6]. However, there
is still data supporting an inverse relationship between HDL-c
levels and risk of coronary heart disease [3,7], and HDL-c remains
a prevention cornerstone in major treatment guidelines [8].
It has been described that low HDL-c has two distinct patterns,
50% of cases have accompanying other dyslipidaemia and 50% have
isolated low HDL-c, i.e. low HDL-c in the absence of other lipo-
protein abnormalities [9]. Those with isolated low HDL-c have 20%
additional risk of developing cardiovascular disease compared to
people with normal levels of HDL-c [10]. On the other hand, other
21-year follow-up study did not ﬁnd an association between iso-
lated low HDL-c and coronary heart disease mortality when
compared to people with high HDL-c [11]. These reports on the role
of isolated low HDL-c as a major cardiovascular risk factor signal to
an area of ongoing debate.
Several studies have reported prevalence of low HDL-c in
different settings, yet very few have contrasted HDL-c proﬁles of
rural versus urban populations [12,13]. In the same vein, potential
differences in HDL-c proﬁles based on migration status have not
been thoroughly addressed, thus limiting opportunities to explore
migration-related exposures resulting in lipid abnormalities. In an
ever increasing urbanizing world [14], proﬁles of isolated/non-
isolated low HDL-c and its relationship with migration, cardiovas-
cular events and mortality remains to be characterised.
Migration studies intrinsically carry the potential to depict non-
traditional risk proﬁles, and they are key positioned to inform av-
enues for further prevention and therapeutic targets. The aims of
this study were twofold: ﬁrst, to determine the proﬁle of, as well as
to characterize related factors for, HDL-c patterns with a focus on
isolated and non-isolated low HDL-c in three population-based
groups according to their migration status; and second, to deter-
mine the effect of HDL-c patterns on the rates of cardiovascular
outcomes (i.e. non-fatal stroke and non-fatal myocardial infarction)
and mortality.
2. Materials and methods
2.1. Study design, setting and participants
Data from the PERU MIGRANT study was analysed. Baseline
assessment (conducted in 2007e2008) provided data for the cross-
sectional analysis, and the follow-up assessment, after 5 years from
baseline (2012e2013), was used for the longitudinal analysis.
The characteristics of the PERU MIGRANT study settings and
enrolled participants have been described in detail elsewhere [15].
Brieﬂy, a single-stage random sampling method was used in all
study groups, and this procedure was stratiﬁed by age- and sex-
groups. Rural participants were selected from the adult popula-
tion permanently living in San Jose de Secker in Ayacucho (3239 m
above sea level). Urban participants were born and currently live in
Pampas de San Juan de Miraﬂores, a periurban shantytown in Lima,
Peru, located at sea level. Rural-to-urban migrants were born in
Ayacucho and lived in Pampas de San Juan de Miraﬂores.
2.2. Follow-up assessment
For re-evaluation, participants were re-contacted in the same
setting where they were originally enrolled, thus re-conﬁrming the
rural, migrant and urban group status. Mortality and cardiovascular
events, speciﬁcally non-fatal myocardial infarction and non-fatal
stroke, were collected during the follow-up assessment. Death
certiﬁcates were used to record date and cause of death. When
death certiﬁcates were not available, especially in rural areas, the
participant's relatives were interviewed to verify mortality andcauses [16].
2.3. Variables deﬁnition
LowHDL-cwas deﬁned as HDL-c<40mg/dL inmen and<50mg/
dL in women [8]. For analyses purposes, three groups were created
based on HDL-c values: i) normal HDL-c; ii) non-isolated low HDL-
c, for instance low HDL-c accompanied by hypertriglyceridemia
and/or high LDL-c (LDL-c 160 mg/dL) [8]; and iii) isolated low
HDL, deﬁned as low HDL-c without hypertriglyceridemia (tri-
glycerides 200 mg/dL) and LDL-c<160 mg/dL. In addition, non-
HDL-c was also calculated by subtracting HDL-c from total choles-
terol, and then was categorised, deﬁning 100 mg/dL as high non-
HDL-c [8].
Other participant characteristics included in the analysis as
related factors were age (in four categories, 30e39, 40e49, 50e59
and 60 years old) and gender. Socioeconomic status was analysed
based on a deprivation index, a binary variable where “yes” refers
to a participant in the bottom category of two or more of four
deprivation variables: possessions weighted asset index (in ter-
tiles), total family income per month (<US$150, US$150e250,
>US$250 dollars), overcrowding (three or more people per room in
house) and educational attainment (none/incomplete primary,
complete primary, some secondary or higher). BMI categories
(normal if BMI18.5 and < 25 kg/m2, overweight 25 and < 30 kg/
m2, and obese 30 kg/m2) [17], current daily smoking (if a partic-
ipant reported smoking at least one cigarette per day), heavy
episodic alcohol intake (if participants reported drinkingmore than
6 servings of alcohol on one occasion), and physical activity levels.
The later were categorised according to the International Physical
Activity Questionnaire (IPAQ) as high/moderate if participant per-
formed 5 or more days of any combination of walking, moderate-
intensity, or vigorouseintensity activities achieving at least 600
MET (multiples of the resting metabolic rate) minutes/week or low
if participant performed less than 600 MET minutes/week [18].
Blood pressure wasmeasured three times and the average of the
second and third measurements was used to deﬁne hypertension
as systolic BP  140 mmHg or diastolic BP  90 mmHg, or self-
report of physician diagnosis and currently receiving antihyper-
tensivemedication [19]. Fasting glucosewas used to deﬁne diabetes
if  126 mg/dL [7 mmol/L] or self-report of physician diagnosis
and currently receiving anti-diabetic medication [20].
2.4. Laboratory procedures
Laboratory assessments were performed on venous samples
taken in the morning after a minimum of 8 h fast. Serum glucose,
HDL-c and triglyceride levels were measuring using a Cobas®
Modular Platform automated analyser and reagents supplied by
Roche Diagnostics. The same procedure was used to measure LDL-c
in people with triglycerides greater than 400mg/dL (n¼ 29, 2.9% of
all participants studied). In those with triglycerides below 400 mg/
dL, LDL-c was calculated using the Friedewald equation in mg/dL
[21].
2.5. Exposure and outcomes
For the cross-sectional analysis, the primary exposure of interest
was study group, deﬁned as rural, rural-to-urban migrant, and ur-
ban group.
For the longitudinal analysis the exposure of interest was HDL-c
status at baseline (normal HDL-c, isolated low HDL-c, and non-
isolated low HDL-c). Two set outcomes were pre-deﬁned: ﬁrst,
mortality-only outcomes, i.e. all-causemortality and cardiovascular
mortality, and second, all-cause/cardiovascular mortality plus
HDL-c: high density lipoprotein cholesterol
TG: triglycerides
LDL-c: low density lipoprotein cholesterol
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Fig. 1. Lipid proﬁles in PERU MIGRANT Study at baseline.
M. Lazo-Porras et al. / Atherosclerosis 246 (2016) 36e4338cardiovascular events, namely non-fatal myocardial infarction and
non-fatal stroke.
2.6. Statistical analysis
All statistical analyses were performed using Stata 12.0 (Stata-
Corp, College Station, TX, USA). Prevalence and 95% conﬁdence
intervals (95% CI) of different HDL-c categories were determined
overall (frequency weighted) and by each study group. Chi-squared
was used to address the relationship between sociodemographic
and lifestyle factors with normal HDL, isolated low HDL-c and non-
isolated low HDL.
Using baseline data, different models were generated using
Poisson regression technique with robust variance as reported
previously for cross-sectional data [22,23] to ﬁnd independently
factors associated with our outcome of interest, and reporting
prevalence ratios (PR) and 95% CI. Our ﬁrst model allowed the
comparison of isolated low HDL-c vs. normal HDL-c. A similar
approach was used to compare non-isolated low HDL-c vs. normal
HDL-c.
Using longitudinal data, crude and adjusted regression analysis
was performed for modelling all composite outcomes, having HDL
categories as exposure, and reporting relative risk ratios (RRR) and
95% CI. HDL-c classiﬁcation as used in this manuscript allowed for
the assessment of the independent risk of these proﬁles controlling
for sex, age, deprivation index, and migration status. Adjustment
for baseline LDL-c levels, as suggested in other longitudinal analysis
of the effect of HDL-c on cardiovascular outcomes, was not pursued
as normal (or abnormal) LDC-c level are part of the deﬁnition of
isolated and non-isolated low HDL-c, already included in our
deﬁnition of exposures.
2.7. Ethics
The Institutional Review Board of Universidad Peruana Cayetano
Heredia in Peru approved the protocol for the baseline and follow
up phase. All participants were informed about the objectives of the
study and oral informed consent was obtained due to major illit-
eracy rates.
3. Results
Data from a total of 988 participants was included in the ana-
lyses. Of these, 201 (20.3%) were from the rural group, 588 (59.5%)
from the rural-urbanmigrant group and 199 (20.1%) from the urban
group. The mean age (SD) in rural, rural-to-urban migrant and ur-
ban areas was 48.3 (SD 13.1), 47.8 (SD 11.7) and 48.1 (SD 11.9) years,
respectively. (See Supplementary Material 1).
3.1. Low HDL-c proﬁles in the study population
LowHDL-c was present in 562/988 (56.5%; 95% CI 53.4%e59.6%),
whereas isolated low HDL-c was present only in 387/988 (36.5%;
95% CI 33.5%e39.5%). In addition, high non-HDL-c was present in
843/988 (91.6%; 95% CI 89.8%e93.3%). Other combinations of lipid
proﬁle patterns are depicted in Fig. 1. Of note, none of the partici-
pants reported taking statins and only 3.7% reported to take anti-
hypertensive drugs.
3.2. HDL-c patterns by sociodemographic and lifestyle factors
Isolated low HDL-c was present in 47.3% of rural, 38.1% of rural-
urban migrants, and 34.2% of urban individuals (p ¼ 0.02) with a
pattern of gradients in prevalence between groups. The same
pattern (rural > migrants > urban), but more marked, was presentamong females but not males. On the other hand, a different
pattern, urban similar to migrant and both higher than rural, was
observed in both high non-HDL-c and non-isolated low HDL-c
(Table 1).
There was evidence of differences between normal HDL-c, iso-
lated low HDL-c, and non-isolated low HDL-c proﬁles according to
migration status, sex, age, deprivation index, BMI, and alcohol
intake (Table 2).3.3. Factors associated with low HDL-c proﬁles
In multivariable regression analyses, factors positively associ-
ated with higher prevalence of isolated lowHDL-c were rural group
compared to urban, female higher than males, and overweight and
obese categories higher than normal BMI. On the other hand, fac-
tors positively associated with non-isolated low HDL-c included
female gender, being 50e59 years old compared to those aged
30e39 years, as well as overweight and obese status relative to
normal BMI. Although variables included in both models were
similar (except migration status), the strength of association was
higher when comparing non-isolated low HDL-c against normal
HDL-c than those observed with isolated HDL-c (Table 3).3.4. Mortality and cardiovascular events
Of the 988 participants enrolled at baseline in the PERU
MIGRANT study, 895 were re-assessed, 60 (6.1%) were lost to
follow-up, and 33 (3.3%) died. Of the total deaths with information
on cause of death (n ¼ 26), the number of deaths attributable to
cardiovascular events was 9 (34.6%). In addition, a total of ﬁve
(0.6%) individuals reported history of non-fatal myocardial infarc-
tion and 10 (1.2%) reported history of non-fatal stroke during the
follow-up evaluation.
In multivariable models, subjects with non-isolated low HDL-c
had three to four times more cardiovascular outcomes
(RRR ¼ 3.46; p ¼ 0.02) than those in normal HDL-c group at
baseline (Table 4). There was also a positive association between
non-isolated low HDL-c and cardiovascular mortality (RRR ¼ 3.66;
p ¼ 0.21), but its 95% CI span the value one.
Table 1
Prevalence of low HDL-c by migration status and gender.
Rural group (n¼201) Migrant group (n ¼ 588) Urban group (n ¼ 199) p-value
n, %, 95% CI n, %, 95% CI n, %, 95% CI
Low HDL-c
Total 113 (56.2%) 341 (57.9%) 108 (54.3%) 0.642
(49.1%e63.2%) (53.9%e62.0%) (47.1%e61.3%)
By sex
Males (%) 33 (34.7%) 121 (43.4%) 44 (47.8%) 0.174
(25.3%e45.2%) (37.5%e49.4%) (37.3%e58.5%)
Females (%) 80 (75.5%) 220 (71.2%) 64 (59.8%) 0.031
(66.2%e83.3%) (65.8%e76.2%) (49.9%e69.2%)
High non-HDL-c
Total 125 (62.2%) 533 (90.7%) 185 (92.9%) <0.001
(55.1%e68.9%) (87.9%e92.9%) (88.5%e96.1%)
By sex
Males (%) 56 (58.9%) 255 (91.4%) 89 (96.7%) <0.001
(48.4%e68.9%) (87.5%e94.4%) (90.8%e99.3%)
Female (%) 69 (65.1%) 278 (89.9%) 96 (89.7%) <0.001
(55.2%e74.1%) (86.1%e93.1%) (82.3%e94.8%)
Isolated low HDL-c
Total 95 (47.3%) 224 (38.1%) 68 (34.2%) 0.019
(40.2%e54.4%) (34.2%e42.2%) (27.6%e41.2%)
By sex
Males (%) 28 (29.5%) 72 (25.8%) 28 (30.4%) 0.61
(20.6%e39.7%) (20.8%e31.4%) (21.3%e40.9%)
Females (%) 67 (63.2%) 152 (49.2%) 40 (37.4%) 0.001
(53.3%e72.4%) (43.4%e54.9%) (28.2%e47.3%)
Non-isolated low HDL-c
Total 18 (8.9%) 117 (19.9%) 40 (20.1%) 0.001
(5.4%e13.8%) (16.7%e23.4%) (14.8%e26.3%)
By sex
Males (%) 5 (5.3%) 49 (17.6%) 16 (17.4%) 0.012
(1.7%e11.8%) (13.3%e22.5%) (10.3%e26.7%)
Females (%) 13 (12.3%) 68(22.0%) 24 (22.4%) 0.078
(6.7%e20.0%) (17.5%e27.0%) (14.9%e31.5%)
Table 2
Sociodemographic and lifestyle characteristics according to normal HDL, isolated low HDL-c and non-isolated low HDL-c.
Normal HDL-c (n ¼ 426) Isolated low HDL-c (n ¼ 387) Non-isolated low HDL-c (n ¼ 175) p-value
n (%) n (%) n (%)
Study group 0.003
Urban 91 (45.7%) 68 (34.2%) 40 (20.1%)
Migrant 247 (42.0%) 224 (38.1%) 117(19.9%)
Rural 88 (43.8%) 95 (47.3%) 18 (8.9%%)
Sex <0.001
Female 158 (30.3%) 259 (49.6%) 105 (20.1%)
Male 268 (57.5%) 128 (27.5%) 70 (15.0%)
Age <0.001
30e39 years 127 (45.0%) 126 (44.7%) 29 (10.3%)
40e49 years 128 (45.4%) 98 (34.8%) 56 (19.8%)
50e59 years 95 (34.9%) 106 (38.9%) 71 (26.1%)
60 years 76 (50.0%) 57 (37.5%) 19 (12.5%)
Deprivation index 0.028
No 307 (44.6%) 251 (36.5%) 130 (18.9%)
Yes 119 (39.7%) 136 (45.3%) 45 (15.0%)
Daily smoking 0.761
Yes 16 (48.5%) 11 (33.3%) 6 (18.2%)
No 408 (42.8%) 376 (39.5%) 169 (17.7%)
Heavy Episodic Alcohol intake 0.002
Low 373 (41.4%) 366 (40.6%) 162 (17.9%)
High 53 (60.9%) 21 (24.1%) 13 (14.9%)
Physical activity 0.341
Moderate/high 310 (42.7%) 293 (40.4%) 123 (16.9%)
Low 110 (43.3%) 92 (36.2%) 52 (20.5%)
BMI <0.001
Normal 229 (55.6%) 149 (36.2%) 34 (8.3%)
Overweight 142 (37.8%) 158 (42.0%) 76 (20.2%)
Obese 54 (27.3%) 79 (39.9%) 65 (32.8%)
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Table 3
Factors associated with isolated low HDL-c and non-isolated low HDL-c.
Isolated low HDL-c vs. normal HDL-c Non-isolated low HDL-c vs. normal HDL-c
Crude model Multivariable modela Crude model Multivariable modela
PR (95% CI) PR (95% CI) PR (95% CI) PR (95% CI)
Study group
Urban 1 (Reference) 1 (Reference) 1 (Reference) 1 (Reference)
Migrant 1.11 (0.91e1.36) 1.11 (0.91e1.35) 1.05 (0.78e1.42) 1.09 (0.83e1.45)
Rural 1.21 (0.97e1.52) 1.34 (1.01e1.77) 0.56 (0.34e0.91) 0.86 (0.50e1.49)
Sex
Male 1 (Reference) 1 (Reference) 1 (Reference) 1 (Reference)
Female 1.92 (1.64e2.26) 1.75 (1.48e2.08) 1.93 (1.49e2.49) 1.49 (1.14e1.96)
Age
30 - 39 years 1 (Reference) 1 (Reference) 1 (Reference) 1 (Reference)
40e49 years 0.87 (0.71e1.06) 0.90 (0.75e1.09) 1.64 (1.10e2.43) 1.40 (0.95e2.06)
50e59 years 1.06 (0.88e1.27) 1.09 (0.92e1.29) 2.30 (1.58e3.34) 1.90 (1.32e2.73)
60 years 0.86 (0.68e1.09) 0.87 (0.69e1.09) 1.08 (0.64e1.81) 1.07 (0.64e1.78)
Deprivation index
No 1 (Reference) 1 (Reference) 1 (Reference) 1 (Reference)
Yes 1.19 (1.02e1.37) 1.11 (0.91e1.35) 0.92 (0.69e1.23) 1.34 (1.02e1.75)
BMI
Normal 1 (Reference) 1 (Reference) 1 (Reference) 1 (Reference)
Overweight 1.34 (1.13e1.58) 1.45 (1.22e1.72) 2.70 (1.88e3.88) 2.54 (1.72e3.75)
Obese 1.51 (1.25e1.82) 1.45 (1.18e1.78) 4.23 (2.96e6.02) 3.32 (2.19e5.03)
Smoke daily
No 1 (Reference) 1 (Reference) 1 (Reference) 1 (Reference)
Yes 0.85 (0.54e1.35) 1.08 (0.69e1.68) 0.93 (0.46e1.87) 1.12 (0.56e2.22)
Heavy Episodic Alcohol intake
Low 1 (Reference) 1 (Reference) 1 (Reference) 1 (Reference)
High 0.57 (0.40e0.83) 0.72 (0.51e1.03) 0.65 (0.39e1.08) 0.92 (0.53e1.61)
Physical activity
Moderate/high 1 (Reference) 1 (Reference) 1 (Reference) 1 (Reference)
Low 0.94 (0.79e1.11) 0.95 (0.79e1.13) 1.12 (0.86e1.48) 0.94 (0.73e1.22)
Bold stands out some prevalences ratio or risk ratio with a signiﬁcant conﬁdence interval.
a Multivariable models were adjusted by all other variables listed in the table. Further adjustment for hypertension or diabetes status in each of these models did not alter
the PR and 95% CIs (data not shown).
Table 4
Risk factors for mortality and composite outcome in the PERU MIGRANT study.
All-cause mortality Cardiovascular Mortality
Bivariate model Multivariable modela Bivariate model Multivariable modela
RRR (95% CI) RRR (95% CI) RRR (95% CI) RRR (95% CI)
HDL-c category
Normal HDL-c 1(Reference) 1(Reference) 1(Reference) 1(Reference)
Isolated low HDL-c 0.69 (0.33e1.49) 1.11 (0.49e2.51) 0.18 (0.02e1.49) 0.45 (0.05e4.24)
Non-isolated low HDL-c 0.44 (0.13e1.51) 0.82 (0.21e3.15) 0.83 (0.17e4.08) 3.67 (0.48e28.16)
All-cause mortality or non-fatal stroke or non-fatal
myocardial infarction
Cardiovascular mortality or non-fatal stroke or non-
fatal myocardial infarction
HDL-c category
Normal HDL-c 1(Reference) 1(Reference) 1(Reference) 1(Reference)
Isolated low HDL-c 1.02 (0.54e1.95) 1.49 (0.77e2.89) 1.08 (0.41e2.87) 1.63 (0.68e3.92)
Non-isolated low HDL-c 1.07 (0.47e2.41) 1.69 (0.72e3.99) 2.19 (0.80e5.97) 3.46 (1.23e9.74)
Bold stands out some prevalences ratio or risk ratio with a signiﬁcant conﬁdence interval.
a Multivariable models were adjusted by sex, age, deprivation index, and migration status.
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4.1. Main ﬁndings
In this study, we found that low HDL-c was the most frequent
pattern of dyslipidaemia: it was present in nearly half of partici-
pants and, noticeably, isolated low HDL-c was present in almost
40% of the total study population. There were some notorious
patterns of differences in prevalence between study groups
depending of the HDL-c variable of interest.
In multivariable cross-sectional analyses, and relative to the
urban subjects, rural individuals had more probability to have ahigher prevalence of isolated low HDL-c but it was not the case for
non-isolated low HDL-c. Finally, in longitudinal analyses, only non-
isolated low HDL-c was associated with a three-to fourfold higher
risk of cardiovascular endpoints using a composite outcome that
included cardiovascular mortality, non-fatal myocardial infarction,
and non-fatal stroke.4.2. Prevalence of isolated and non-isolated low HDL-c
A systematic review assessing cardiovascular risk factors in ur-
ban, rural and migrant populations reported a gradient in which
BMI, total cholesterol, LDL-c, and fasting blood glucose were higher
M. Lazo-Porras et al. / Atherosclerosis 246 (2016) 36e43 41in urban residents than migrants, and higher in migrants than rural
dwellers, but evidence was weak to explore HDL-c in migrant
versus non-migrant groups [24]. Our analysis showed a similar
pattern of gradients among female subjects, but in the opposite
direction, raising further questions about the role of low HDL-c in
rural women, particularly in long-term outcomes.
Previous studies in Peruvian [25e27] and Latin American set-
tings [28] have reported high overall rates of lowHDL-c. Speciﬁcally
for rural and high-altitude settings, other studies have shown low
HDL-c frequencies varying from 45.3% to 77% [27,29]. The high
frequency of low HDL-c observed in Peru differs substantially when
compared to other settings. For example, in the CARMELA study, a
study of seven urban Latin American capitals and major cities, low
HDL-c was reported as the most common dyslipidaemia of all lipid
abnormalities [30]. In this study, Lima had the highest prevalence of
low HDL-c (57%) much higher than the prevalence reported for
Buenos Aires (16%), and Mexico City, Quito and Santiago de Chile
(~22%) [30]. Beyond the Latin American context, the prevalence of
low HDL-c found in our study are higher than those reported in
other studies [25,26,28,29,31], including Haiti (25%), France (30%),
Portugal (36%), Italy (43%), and the Unites States (33%) [31e33].
4.3. Proﬁle of isolated and non-isolated low HDL-c
Results from CARMELA's urban sites, using a cut-off point of
40 mg/dL to deﬁne low HDL in both sexes, showed that the fre-
quency of low HDL-c was higher in males than females [30]. But,
when rural sites are investigated, using the same deﬁnition for low
HDL used in our analyses, this pattern is reversed, i.e. low HDL-c is
more prevalent among females than males [26,27,34], in line with
our ﬁndings. Our study expands in pointing out that much of this
difference can be attributed to isolated low HDL-c.
Isolated low HDL-c was the more common dyslipidaemia in our
study, with a prevalence varying from 34% in urban group to 47% in
the rural group. In other settings, the prevalence of isolated low
HDL-c appears to be much lower, e.g. 22% among Asians and 14% in
New Zealand or Australia [13]. Nevertheless, rates showed in our
study are similar to those found in India, where isolated low HDL-c
was present in 45% of the overall population, with signiﬁcant dif-
ferences between urban (39%) and rural (47%) areas [12].
The high prevalence of low HDL-c observed merits some
explanation, albeit difﬁcult, as environmental or genetic factors
could well play a role in the patterns observed. NHANES III data
showed that the prevalence of low HDL-c in Mexican American
women appears to be higher compared to US white or black fe-
males [35], but no differences were observed in males, pointing
towards a genetic driver, particularly in women, as all groups share
similar US-based environment. In another study, Mexican-
Americans born in Mexico or in the US but currently residing in
the US were found to have up to 80% lower chances of having low
HDL-c relative to Mexicans in Mexico [36], introducing further
challenges into the roles of genetics versus environment.
Overweight and obesity were consistently associated with iso-
lated and non-isolated low HDL-c, but the magnitude of the asso-
ciationwas stronger in the case of non-isolated HDL-c proﬁle. Thus,
whereas obesity increased almost 50% the probability of having
isolated low HDL-c, this was 250% for non-isolated low HDL-c. It is
well known that obesity causes hypertriglyceridemia, high LDL-c
and low HDL-c, and of all of these adverse lipid proﬁles hyper-
triglyceridemia is the most frequent abnormality because of
delayed clearance of the triglycerides-rich lipoproteins and for-
mation of LDL-c [37]. For example, a study from China showed that
participants with BMI 28 kg/m2 had 46% higher odds of having
low HDL-c [38].
Diet is another important behaviour as HDL-c levels have beenreported to be signiﬁcantly lower in the highest tertile of carbo-
hydrate intake than the lowest tertile, even after adjustment for
obesity and other confounders [39]. Also, in societies in transition,
there is some evidence that people from rural areas are consuming
more carbohydrates than in urban settings [40e42], a plausible,
albeit partial, explanation for our ﬁndings. Living at high altitude
areas requires physiological adaptations, which in turn may pro-
vide additional avenues for explanations. Literature reports that
higher HDL-c levels have been observed in high altitude compared
to low-altitude groups, but this is contradictory to our ﬁndings [43].4.4. Mortality and cardiovascular events
Low HDL-c has been extensively described as a risk factor for
cardiovascular events and mortality. However, a recent study
shows that an increase in 1 standard deviation due to genetic
score 14 common single nucleotide polymorphisms associated to
higher HDL-c levelsd was not actually protective of myocardial
infarction. Also, it has been reported that people with high HDL-c
inevitably tend to have lower non-HDL-c [4]. As a result, current
evidence support that high non-HDL-c is related to coronary heart
disease and cardiovascular death [44], which in our setting raises
further concern given the high prevalence of high non-HDL-c, up to
90%, reported in this study. We also found an increased risk of
cardiovascular mortality, non-fatal stroke and non-fatal myocardial
infarction among those with non-isolated low HDL-c, but not with
isolated low HDL-c. Other study in Asians found isolated low HDL-c
were as strongly associated with coronary heart disease risk (haz-
ard ratio, 1.67 [95% CI, 1.27e2.19]) as non-isolated low HDL-c (1.63
[95% CI, 1.24e2.15]). However, this study did not ﬁnd association
with stroke and did not assess mortality as outcome [10].
The trajectories of individuals who shift locations and lifestyles
across a diversity of scenarios connected to rural-urban migration
processes, together with environmental complexities, e.g. low/
high-altitude and/or rural/urban areas, will shape exposure pat-
terns: who is exposed to what (combination of) factors, to what
extent, and in which critical periods of life [45,46]. Isolated and
non-isolated HDL-c as amarker of long-term risk for hard outcomes
requires a much ﬁner understanding of these relationships,
including the diversity of functionalities of the HDL-c [47]. Whilst
physical activity is more common in rural people [48], urban resi-
dents tend to have greater economic advantage including higher
education levels that could affect dietary quality or choices.
Therefore, detailed attention to these patterns, both linked to HDL-
c and lipid proﬁles in general, are required to pursue understanding
of the relationship between HDL-c levels and cardiovascular risk.4.5. Strengths and limitations
Some strengths and limitations deserve consideration. This
study expands on previous knowledge about low HDL-c patterns in
Latin American population taking advantage of a dataset that
allowed comparisons according to migration status in rural/urban
settings. However, other variables that may be related to HDL-c
levels such as dietary patterns, contraceptive, thyroid hormone
and hormone therapy use, or menopause were not addressed by
the PERUMIGRANT study and could not be included in this analysis.
Another limitation is the small number of deaths and cases with
cardiovascular events (i.e. non-fatal myocardial infarction and non-
fatal stroke), thus limiting the power for some analyses as evi-
denced by wide conﬁdence intervals. Also, the cause of death
comes from certiﬁcates and family report, and cardiovascular
events were self-reported. As a result, some risk of misclassiﬁcation
might arise. Further studies are needed to corroborate our ﬁndings.
M. Lazo-Porras et al. / Atherosclerosis 246 (2016) 36e43425. Conclusion
In summary, low HDL-c is very common and isolated low HDL-c
was the predominant proﬁle. Isolated HDL-c occurs more
frequently in rural and female groups, and excess body weight is
directly related to both isolated and non-isolated low HDL-c but
with different magnitudes of association. Also, cardiovascular end
points were only associatedwith non-isolated low-HDL-c. For these
reasons to what extent low HDL-c contributes to the burden of
cardiovascular disease in societies in transition merits attention,
and migration studies can be well positioned to unveil distinct
proﬁles through investigation of different human-gene-
environment interactions, enabling newer avenues for further
prevention and the identiﬁcation of therapeutic targets.
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